During the past decade, Fundeni Clinical Institute conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 42 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 26 clinical trials were completed. i.e. 123.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundeni Clinical Institute" #1 sponsor was "Amgen" with 7 trials, followed by "Celgene" with 7 trials sponsored, "Shire" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Institutul Clinic Fundeni" with 6 trials sponsored. Other sponsors include 71 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundeni Clinical Institute" #1 collaborator was "Institutul Clinic Fundeni" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Centrul de Cercetare in Gastroenterologie si Hepatologie, Craiova" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Fundeni Clinical Institute" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (8 trials), "Colitis, Ulcerative" (4 trials), "Crohn Disease" (4 trials) and "Multiple Sclerosis" (4 trials). Many other conditions were trialed in "Fundeni Clinical Institute" in a lesser frequency.

Most popular intervention types in "Fundeni Clinical Institute" are "Drug" (89 trials), "Other" (10 trials), "Biological" (7 trials), "Procedure" (5 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Carfilzomib" (4 trials), "Cyclophosphamide" (4 trials), "Dexamethasone" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Fundeni Clinical Institute" are 105 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Fundeni Clinical Institute". undefined are not yet recruiting, 16 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Fundeni Clinical Institute, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Fundeni Clinical Institute, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".

Fundeni Clinical Institute has several departments that took part in Clinical trials: "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu" - 6 trials, "Spitalul Clinic "Fundeni" Departament Oncologie Medicala - Gastroenterologie" - 2 trials